Monday, October 26, 2009

CANADA Approves Arepanrix H1N1 AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine:

Contains 5ug Thimerosal per .5ml dose
(Described as '2.5 micrograms 'organic' mercury.)

Contains 10.69 mg Squalene per dose
(Identical to Pandermix.)

No clinical safety date for

Elderly (Over 60)
Children Aged 10 -17
Children Aged 6-35 months
Pregnancy and Lactation

Limited clinical date Children Aged 3-9

Well done, Health Canada!!!

No comments:

Post a Comment